Richard Meyerholz, M.D.
NPI 1144512971 · Rheumatology Physician · Pensacola, FL
Enrolled with Medicare as Practitioner - Rheumatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1144512971
- Entity type
- Individual
- Primary specialty
- Rheumatology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- Yes
- License
- ME126452 (FL)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
15 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,726 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 641 | $88 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 609 | $123 |
| Infusion Into a Vein for Therapy, Prevention, Or Diagnosis, 1 Hour Or Less96365 | 384 | $59 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 370 | $14 |
| Administration of Chemotherapy Into Vein, Each Additional Hour96415 | 189 | $26 |
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 188 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 34 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Methotrexate Sodiumbrand: Methotrexate | 328 | 96 |
| Hydroxychloroquine Sulfate | 241 | 84 |
| Prednisone | 206 | 90 |
| Tramadol Hcl | 129 | 33 |
| Pregabalin | 116 | 50 |
| Gabapentin | 110 | 29 |
| Duloxetine Hcl |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$2,329 across 110 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2011-05-12
- Last updated
- 2016-07-01
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.